The Lens: Ophthalmology Literature Summarized Bi-Weekly
  • Home
  • Recent Issues
  • Question of the Week
  • Landmarks
  • Academy
  • Clarity
  • The Lens Pod
  • Our Team
  • About
  • More
    • Home
    • Recent Issues
    • Question of the Week
    • Landmarks
    • Academy
    • Clarity
    • The Lens Pod
    • Our Team
    • About
The Lens: Ophthalmology Literature Summarized Bi-Weekly
  • Home
  • Recent Issues
  • Question of the Week
  • Landmarks
  • Academy
  • Clarity
  • The Lens Pod
  • Our Team
  • About

In this week’s issue

Join us for upcoming events, from community gatherings to special sales. Preeclampsia and elevated IOP were associated with increased risk of glaucoma development after pregnancy.

  • The HOTV test identified reduced visual acuity more than HOTV in preschoolers, nearly doubling the referral rate and supporting HOTV screening in children younger than 8 years.
  • An early optogenetics trial showed increased light sensitivity in 7 out of 10 patients with retinitis pigmentosa following gene therapy and specialized goggle use.
  • A multicenter study found that lid margin keratinization and conjunctivalization predicted surgical intervention, while certain medications were associated with subsequent vision loss.We can't wait to see you there.







This Week's Eye-Openers

Subscribe

Case of the Week

AJOCR

Summary written by Rahul Nanduri

Borrowing from the retinoblastoma playbook

A 1-month-old male presented with a left orbital mass, which was initially diagnosed as a capillary hemangioma. After a four-week trial of oral propranolol without any improvement, magnetic resonance imaging revealed an enlarging, lobulated, intraconal mass.

Biopsy and DNA methylation array analysis identified the lesion as an embryonal tumor with multilayered rosettes (ETMR), an aggressive neoplasm not previously reported in the orbit. Germline genetic testing revealed a DICER1 mutation, and the tumor itself harbored a second, distinct somatic DICER1 mutation, consistent with the “two-hit” mechanism. ETMR carries a poor prognosis, and no established treatment protocol exists for orbital involvement.

During discussions for the patient’s care plan, the family declined exenteration, and the care team instead offered intraarterial chemotherapy, an approach with no prior reported use in DICER1-mutated orbital ETMR (but well established for retinoblastoma). After four monthly outpatient treatment sessions, the mass regressed promptly, and serial imaging showed no recurrence at 23 months of follow-up, achieved without surgery, radiation, or systemic chemotherapy.

This case illustrates that intraarterial chemotherapy may offer an effective, vision- and life-preserving alternative for rare orbital embryonal tumors, and reinforces the value of germline DICER1 testing and methylation profiling in atypical pediatric orbital masses.


Question of the Week

You are a resident on the cornea service when a 60-year-old woman is referred to your clinic for evaluation of corneal edema in the right eye and possible surgical management. Three years ago, she underwent cataract extraction of a dense nucleus with IOL implantation in the right eye. She tells you that her vision in that eye has progressively worsened since the time of surgery. Her eye is uncomfortable, but she denies new floaters, flashes of light, and any history of ocular trauma.  Vision is CF at 3 feet OD and 20/20 OS. Pachymetry is notable for a corneal thickness of 710 μm OD and 550 μm OS. The right cornea has subepithelial bullae on the superior third of the cornea, an irregular surface, and 2-3+ corneal edema. Slit lamp photograph is shown below.


What is the most likely diagnosis?

A. Fuchs’ endothelial dystrophy

B. Band keratopathy

C. Pseudophakic bullous keratopathy

D. Limbal stem cell deficiency


Click Here For Answers!

Follow The Lens on Twitter/X!

Contact Us

Follow us on Twitter @TheLens_Oph and Instagram @TheLens_Oph

 

Contact us if you have inquiries for advertisements, questions, or general feedback for The Lens – we’re always looking to improve!

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Content of The Lens is for medical education purposes only.


Copyright © 2021 The Lens Newsletter LLC - All Rights Reserved.

Powered by

  • Question of the Week
  • Landmarks
  • The Lens Pod
  • Lens AI